Get notified when WST files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: WST WEST PHARMACEUTICAL SERVICES INC 8-K

West Pharmaceutical Services reports Q1 2026 earnings, furnishes results via 8-K

Filed April 23, 2026 · Period ending April 23, 2026 · ~1 min read

Key Changes

  • high

    West Pharmaceutical announced first-quarter 2026 financial results through a press release dated April 23, 2026. Actual financial figures and performance metrics are contained in the attached exhibit rather than the 8-K body.

  • medium

    The company made investor presentation materials available on its website and as an exhibit, providing additional context beyond the basic earnings release for the quarterly investor call.

  • low

    The 8-K is being 'furnished' rather than 'filed' under standard practice for earnings releases, limiting legal liability and preventing automatic incorporation into other SEC filings.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.

Partner

Trade WST commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?